One of the listed companies, The IBN SINA Pharmaceutical Industry PLC, discloses its financial reports for the third quarter, (January – March 23). This source is known from DSE.
The company’s consolidated earnings per share (EPS) of Tk 2.99 paisa in Q3 of the current financial year. Consolidated EPS was Tk 2.76 paisa during the same period last year.
Consolidated NAV per share was Tk. 90.82 as on March 31, 2023.
Share this
